104 related articles for article (PubMed ID: 4720261)
1. [Anginin in the treatment of coronary artery disease].
Markiewicz M; Korolko A; Jaroszyński G
Pol Tyg Lek; 1973 Jun; 28(23):871-3. PubMed ID: 4720261
[No Abstract] [Full Text] [Related]
2. [Antilipemic and coronary-active treatment of arteriosclerosis: clinical experience].
Poggio R; Velle G
Clin Ter; 1978 Jul; 86(2):129-35. PubMed ID: 743855
[No Abstract] [Full Text] [Related]
3. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents].
Plastinina RA; Oleĭnik NA; Valeeva RM; Pavlova TN
Sov Med; 1984; (1):83-7. PubMed ID: 6701660
[No Abstract] [Full Text] [Related]
4. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
[No Abstract] [Full Text] [Related]
5. [Atheroid and anginin in diabetic retinopathy].
Margolis MG; Zefirova GS; Shul'pina NB
Vestn Oftalmol; 1973; 1():38-41. PubMed ID: 4130225
[No Abstract] [Full Text] [Related]
6. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
Liusov VA; Belousov IuB; Martynov AI; Koroleva SA; Zimin VS
Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
[No Abstract] [Full Text] [Related]
7. [Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
Grigor'ian VA; Klantsa NA; Prishliak VD; Klantsa PN
Vrach Delo; 1981 Oct; (10):13-5. PubMed ID: 6795820
[No Abstract] [Full Text] [Related]
8. [Pyridinolcarbamate treatment of ischemic heart disease].
Kuz'ko NV
Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
[No Abstract] [Full Text] [Related]
9. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Valiensi M; Riboli E; Lombardi M
Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
[No Abstract] [Full Text] [Related]
10. [Sulodexide in the therapy of vasculopathies].
Postiglione F; Pisani P; Gisonni P; Perrotta P; Gisonni A; Canciello M; Napolitano L; Brighina G; Ragno I; Salzano A
Clin Ter; 1986 May; 117(3):223-31. PubMed ID: 3524974
[No Abstract] [Full Text] [Related]
11. [Regression of arteriosclerosis. Results of animal experiments and human medical studies, results of drug therapy].
Kaffarnik H; Zehner J
Fortschr Med; 1985 May; 103(20):531-4. PubMed ID: 4007752
[No Abstract] [Full Text] [Related]
12. Editorial on CHD.
Riesen WF
J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S1-2. PubMed ID: 9044998
[No Abstract] [Full Text] [Related]
13. Lipids and their role in coronary heart disease: what they do and how to manage them.
Pradka LR
Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283
[TBL] [Abstract][Full Text] [Related]
14. [Thiadenol in the short-term treatment of patients with blood lipid disorders].
Di Stefano F; Patane S; Gatto A
Minerva Med; 1980 Mar; 71(8):567-74. PubMed ID: 7360386
[TBL] [Abstract][Full Text] [Related]
15. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
[No Abstract] [Full Text] [Related]
16. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
[No Abstract] [Full Text] [Related]
17. [Comparative study of the action of hypolipemic and antioxidant drugs in ischemic heart disease].
Kalmykova VI; Nikitina EK; Bezzubov AA
Sov Med; 1986; (3):81-4. PubMed ID: 3520867
[No Abstract] [Full Text] [Related]
18. [Necessity of hypolipemic treatment in patients with coronary disease].
Fernández-Miranda C; Aranda IL
Med Clin (Barc); 1999 Mar; 112(11):438. PubMed ID: 10231779
[No Abstract] [Full Text] [Related]
19. [Antilipemics and atherosclerosis].
Chiche P; Chekler P; Ribadeau-Dumas JL; Derrida R
Coeur Med Interne; 1967 Apr; 6(2):235-43. PubMed ID: 5618970
[No Abstract] [Full Text] [Related]
20. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
Meciani L; Boeri S; Ricci G
Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
